Intra-tumoral bacteria in breast cancer and intervention strategies
Advanced Drug Delivery Reviews · 2025-02 · 217 · 115516
DOI: 10.1016/j.addr.2025.115516 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2025-02. Verfasst von Ting Hou und 3 weiteren Autor:innen. Beteiligte Einrichtung: NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-M…. Hauptthemen laut MEDLINE: Breast Neoplasms, Microbiota, Bacteria. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 113 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Bureau, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
The microbiome, consisting of a wide range of both beneficial and harmful microorganisms, is vital to various physiological and pathological processes in the human body, including cancer pathogenesis. Tumor progression is often accompanied by the destruction of the vascular system, allowing bacteria to circulate into the tumor area and flourish in an immunosuppressive environment. Microbes are recognized as significant components of the tumor microenvironment. Recent research has increasingly focused on the role of intra-tumoral bacteria in the onset, progression, and treatment of breast cancer-the most prevalent cancer among women. This review elucidates the potential mechanisms by which intra-tumoral bacteria impact breast cancer and discusses different therapeutic approaches aimed at targeting these bacteria. It provides essential insights for enhancing existing treatment paradigms while paving the way for novel anticancer interventions. As our understanding of the microbiome's intricate relationship with cancer deepens, it opens avenues for groundbreaking strategies that could redefine oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical…
Förderung
- Guangzhou Municipal Science and Technology Bureau
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Hou, T., Huang, X., Lai, J., & Zhou, D. (2025). Intra-tumoral bacteria in breast cancer and intervention strategies. Advanced Drug Delivery Reviews, 217, 115516. https://doi.org/10.1016/j.addr.2025.115516
Vancouver
Hou T, Huang X, Lai J, Zhou D. Intra-tumoral bacteria in breast cancer and intervention strategies. Advanced Drug Delivery Reviews. 2025;217:115516. doi:10.1016/j.addr.2025.115516
BibTeX
@article{Hou2025,
author = {Hou, Ting and Huang, Xiaoling and Lai, Jiahui and Zhou, Dongfang},
title = {Intra-tumoral bacteria in breast cancer and intervention strategies},
journal = {Advanced Drug Delivery Reviews},
year = {2025},
volume = {217},
pages = {115516},
doi = {10.1016/j.addr.2025.115516}
}
EUVIMED